Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers (2023)

First Author: Van Zalm P

Attributed to: Neuropathological and amyloid peptide differences between DS and familial AD with duplications and missense mutations in APP gene funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Cell Reports Medicine

Issue: 4